Only 5% of patients with EOAD carry a pathogenic variant in the AD genes (APP, PSEN1, and PSEN2 coding for the amyloid precursor protein, the presenilin 1 and 2, respectively) or the apolipoprotein E (APOE) ε4 allele. This evidence concerns the gene PSEN1 and Alzheimer disease.